Intracerebral Hemorrhage Clinical Trial
Official title:
Predicting Long Term Survival in Patients With Primary Intracerebral Hemorrhage. Development and Validation of the ICHCat in Primary Care.
The clinical evidence shows that patients with a first episode of intracerebral hemorrhage
(ICH) are increasingly old and with greater comorbidity with a recognized impact over
mortality. The prediction of the outcome of ICH is not only crucial in the emergin attention
to identify those patients with favorable criteria that can benefit from possible treatments;
but also after hospital discharge, in primary care where the prediction should facilitate the
organization and management of a wide variety of resources: familiar, health and social
welfare. Even though there are different scales that predict mortality, these are not
sufficiently useful in choosing a treatment or do not provide sufficient data to the family
to decide.
Due to the characteristics of the population with ICH described in these works, it seems
useful to propose a prognostic index (ICHCat) to identify the variables associated to its
incidence and mortality and that, in addition, to make adjustments in the comparisons of the
survival between different series of patients or different treatment modalities in primary
care.
The authors carried out a multicentric and retrospective study of a cohort with an episode of
ICH in the period between 2006-2016. The objective of this phase is to design a predictive
index (ICHCat) of mortality in patients with an episode of ICH. Patient outcome was followed
until death all causes or study end (30.09.2016) since date of ICH in the electronic health
record. All people included were managed by the Public Health System in Catalonia. Registry
information was collected from the government-run healthcare provider responsible for all
inpatient care in the county.
Predictor Variables
Predictor variables were considered if they were viewed as commonly measured and available in
primary care and with potential evidence of an association with ICH risk. Candidate variables
included:
Sex: woman (0) man (1) Age: <80 year-old (1), ≥80 year-old (2). Number CCP criteria: <4 (0)
≥4 (1). Charlson comorbidity index. Short version. Current medications were asked about
during the home visit and confirmed in medical records. Polypharmacy (defined as five or more
daily medications): <5 (0), between 5-9 (1), and ≥10 (2). Oral anticoagulants (acenocumarol
or warfarin) with TTR ≥60% (1), if TRT <60% (2) or New Oral Anticoagulants NOACs (0).
Antidepressants and/or, sedating or other drugs affecting the neurologic system: man (1),
woman (2). If there was a diagnostic of "atrial fibrillation", CHA2DS2VASC and HAS-BLED
scores were included.
Recurrent falls or fall risk: no (0), yes (1). Hypertension not controlled by therapy (≥
160/90 mmHg): no (0), yes (1). BP was measured as an average of separated follow-up
measurements last six months.
Alcoholism abuse vs dependence: no (0), yes (1) Presence de cognitive impairment: a
disease-specific diagnosis of cognitive impairment and/or prescription of specific treatment,
without specification of sub-type or severity, was used and mesured by Pfeiffer test [2]:
[0-2 errors] = Intact Intellectual Functioning (1); [≥3 errors] = Mild to severe Intellectual
Impairment (2)].
Presence de disability: score in [Barthel ≥60 (1) <60 (2)] or in [Rankin <4 (1) 5(2)] were
used to assess dependence in ADL Functional status: (0) Autonomus (1) Residual with caretaker
(2) Dependence with caretaker (3) Long stay
Socio familiar risk: score in Gijon[18] scale 10-14 (1) ≥15 (2)]
Primary Outcome Given the limited survival, the primary outcome was death all causes
occurring within the 5-year follow-up after the ICH episode.
Predictions of ICH mortality risk were based on Cox proportional-hazards regression models.
All potential predictors were considered in a multivariate logistic regression, and a
backward step selection procedure was carried out to pick the variables that composed the
best model. Subsequently design a predictive model of multivariate Cox regression analysis to
define the weight of each of the pathologies in the mortality. To assign the weight according
to the value HR took into account only those with a HR ≥1.2 in the multivariate model
approximating the value of HR to the nearest whole number:
- HR between 1.20 and 1.49 scored with 1.
- HR between 1.50 and 2.49 with 2.
- HR between 2.50 and 3.49 received 3, and so on.
The final score for each patient (ICH) was made up of the sum of their scores by age and
comorbidity. To check the validity of the index we define the following levels of mortality
risk:
- Low risk: 0-1 points.
- Medium Risk: from 2 to 5 points.
- High Risk: of 6 or more points.
The authors estimate the survival probability of each risk group according to the
Kaplan-Meier method and compared these curves using the Log-Rank test. It will be used ROC
curves i the AUC to assess the ability of the index ICH to perform properly the assignment of
patients to different risk groups. The hazard ratio according to the proportional hazards
model categorized in their levels of risk, in order to observe the increase in the risk of
death that occurs from a risk group to the next. The statistical analysis consisted of a
multivariate logistic regression model. The model selection has been caried out with an
AIC-led forward step selection method. To ensure internal validity, 20% of data has been
discarded in the phase of constructing the model and only used to assess model performance
using ROC curves and the AUC.
In a second phase, there will be a retrospective study of validation in the cohort of
patients PCC of the territory with an episode of ICH.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05089331 -
ROSE-Longitudinal Assessment With Neuroimaging
|
||
Recruiting |
NCT03605381 -
MORbidity PRevalence Estimate In StrokE
|
||
Active, not recruiting |
NCT04522102 -
Antiplatelet Secondary Prevention International Randomised Trial After INtracerebral haemorrhaGe (ASPIRING)-Pilot Phase
|
Phase 3 | |
Terminated |
NCT04178746 -
PRONTO: Artemis in the Removal of Intraventricular Hemorrhage in the Hyper-Acute Phase
|
||
Not yet recruiting |
NCT03956485 -
Multicentre Registry of Patients With Spontaneous Acute Intracerebral Hemorrhage in Catalonia (HIC-CAT).
|
||
Enrolling by invitation |
NCT02920645 -
Multicenter Validation of the AVICH Score
|
N/A | |
Recruiting |
NCT02625948 -
Tranexamic Acid for Acute ICH Growth prEdicted by Spot Sign
|
Phase 2 | |
Completed |
NCT02478177 -
Addressing Real-world Anticoagulant Management Issues in Stroke
|
||
Completed |
NCT01971359 -
Clinical Outcomes Following Parafascicular Surgical Evacuation of Intracerebral Hemorrhage: A Pilot Study
|
N/A | |
Terminated |
NCT00990509 -
Albumin for Intracerebral Hemorrhage Intervention
|
Phase 2 | |
Completed |
NCT01261091 -
Early Tracheostomy in Ventilated Stroke Patients
|
N/A | |
Completed |
NCT00716079 -
The Second Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial
|
N/A | |
Recruiting |
NCT00222625 -
rFVIIa in ICH in Patients Treated With Anticoagulants or Anti-Platelets
|
Phase 2 | |
Recruiting |
NCT05095857 -
The Anesthetic Ketamine as Treatment for Patients With Severe Acute Brain Injury
|
Phase 4 | |
Recruiting |
NCT04548596 -
NOninVasive Intracranial prEssure From Transcranial doppLer Ultrasound Development of a Comprehensive Database of Multimodality Monitoring Signals for Brain-Injured Patients
|
||
Not yet recruiting |
NCT06429332 -
International Care Bundle Evaluation in Cerebral Hemorrhage Research
|
Phase 4 | |
Recruiting |
NCT05492474 -
Cranial Ultrasound for Prehospital ICH Diagnosis
|
N/A | |
Not yet recruiting |
NCT05502874 -
Multicenter Registry for Assessment of Markers of Early Neurological Deterioration in Primary Intracerebral Hemorrhage
|
||
Recruiting |
NCT04604587 -
MRI-visible Enlarged Perivascular Spaces and the Alteration of Lymphatic Drainage System in CAA
|
Phase 3 | |
Recruiting |
NCT05504941 -
Detection of an Endovascular Treatment Target in Patients With an Acute, Spontaneous Intracerebral Hemorrhage
|
N/A |